# A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome

> **NCT04933292** · PHASE4 · UNKNOWN · sponsor: **Xiaoli Fan** · enrollment: 78 (estimated)

## Conditions studied

- Autoimmune Hepatitis
- Primary Biliary Cirrhosis

## Interventions

- **DRUG:** Methylprednisolone and Mycophenolate mofetil
- **DRUG:** Methylprednisolone and azathioprine

## Key facts

- **NCT ID:** NCT04933292
- **Lead sponsor:** Xiaoli Fan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-16
- **Primary completion:** 2022-05
- **Final completion:** 2022-05
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2021-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04933292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04933292, "A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04933292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*